Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML

This publication has 48 references indexed in Scilit:

• Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
  Oncogene, 2002
• Direct Binding of the Signal-transducing Adaptor Grb2 Facilitates Down-regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1
  Published by Elsevier ,2001
• Role of abnormal integrin-cytoskeletal interactions in impaired β1 integrin function in chronic myelogenous leukemia hematopoietic progenitors
  Experimental Hematology, 1999
• Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors
  Leukemia, 1998
• Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.
  Journal of Clinical Investigation, 1996
• CRKL Links p210BCR/ABL with Paxillin in Chronic Myelogenous Leukemia Cells
  Journal of Biological Chemistry, 1995
• Integrins: Emerging Paradigms of Signal Transduction
  Annual Review of Cell and Developmental Biology, 1995
• Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.
  Journal of Clinical Investigation, 1995
• Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
  Journal of Clinical Investigation, 1994
• The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865]
  The Journal of cell biology, 1994